Congestive Heart Failure News and Research

RSS

Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.

CardioMEMS heart failure sensor reliably safe, effectively reduces hospitalizations

In the year following placement of a CardioMEMS heart failure sensor—designed to wirelessly measure and monitor pulmonary artery pressures that can signal worsening heart failure—patients experienced a 58 percent reduction in hospitalization for heart failure, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. Reductions in hospitalizations were seen in both men and women, across all ejection fraction ranges and regardless of race.

18 Mar 2019

New risk adjustment model could reduce financial penalty for safety net hospitals

New research shows that U.S. safety net hospitals could benefit substantially from a new model that accounts for social risk factors like poverty and living in a disadvantaged neighborhood in determining how the federal government penalizes hospitals financially for their readmission rates.

15 Mar 2019

New guidelines on clinical use of life-saving antibiotics

An international panel of the foremost researchers on infectious disease and antimicrobials has formed new guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat deadly, drug-resistant bacteria.

11 Mar 2019

Early use of norepinephrine could benefit patients with sepsis and low blood pressure

Patients with septic shock who were treated with norepinephrine earlier than patients receiving standard care were more likely to have their blood pressure and shock stabilized within six hours of diagnosis, according to a randomized, double-blind, controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

4 Feb 2019

African-Americans have very high blood pressure 5 times higher than national average

Extremely high blood pressure that leads to strokes, heart attacks and acute kidney damage, classified as hypertensive emergency, is five times higher in inner-city African-American patients than the national average, according to a recent study co-lead by a Rutgers researcher.

31 Jan 2019

Benzodiazepines may improve survival in congestive heart failure

A study published in the current issue of Psychotherapy and Psychosomatics indicates that treatment of anxiety with benzodiazepines may improve survival in congestive heart failure.

23 Jan 2019

New project develops more efficient treatment approaches for cardiovascular diseases

Within the framework of a European collaborative research project, Oliver Müller, professor at the Faculty of Medicine at Kiel University and Consultant at the Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Campus Kiel, will receive 1.4 million Euros for the project "CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease".

21 Dec 2018

Weight history at ages 20 and 40 could help predict patients' future risk of heart failure

In a medical records analysis of information gathered on more than 6,000 people, Johns Hopkins Medicine researchers conclude that simply asking older adult patients about their weight history at ages 20 and 40 could provide real value to clinicians in their efforts to predict patients' future risk of heart failure, heart attacks or strokes.

12 Dec 2018

Self-care program for COPD patients reduces emergency room visits and burdensome symptoms

Johns Hopkins Medicine researchers report that a program designed to enhance self-care and lead to more seamless management of chronic obstructive pulmonary disease in adults successfully reduced rates of emergency room visits and hospitalization, and the burdensome symptoms and limitations caused by the condition.

21 Nov 2018

Trumpeted new Medicare Advantage benefits will be hard for seniors to find

For some older adults, private Medicare Advantage plans next year will offer a host of new benefits, such as transportation to medical appointments, home-delivered meals, wheelchair ramps, bathroom grab bars or air conditioners for asthma sufferers.

9 Nov 2018

Study highlights need for interventions to improve statin use among older adults

In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

7 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Research explores whether increasing Medicare payments can improve nursing facility care

Regenstrief Institute and Indiana University Center for Aging Research investigators are testing whether providing nursing homes and the doctors and nurse practitioners who care for their residents with increased Medicare payments can further reduce avoidable hospitalizations.

10 Oct 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Congestive Heart Failure News and Research

CardioMEMS heart failure sensor reliably safe, effectively reduces hospitalizations

New risk adjustment model could reduce financial penalty for safety net hospitals

New guidelines on clinical use of life-saving antibiotics

Early use of norepinephrine could benefit patients with sepsis and low blood pressure

African-Americans have very high blood pressure 5 times higher than national average

Benzodiazepines may improve survival in congestive heart failure

New project develops more efficient treatment approaches for cardiovascular diseases

Weight history at ages 20 and 40 could help predict patients' future risk of heart failure

Self-care program for COPD patients reduces emergency room visits and burdensome symptoms

Trumpeted new Medicare Advantage benefits will be hard for seniors to find

Study highlights need for interventions to improve statin use among older adults

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Research explores whether increasing Medicare payments can improve nursing facility care

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

ATS publishes new guideline focused on weight loss strategies for sleep apnea patients

Study aims to investigate risk factors for PPCs in surgical patients with gastric cancer

ATS publishes new guideline on role of weight management in sleep apnea treatment

New NIH grant may help design safer heart pumps

Scientists develop three-pronged model to predict ARDS in burn patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News